[ATHENA] Stem Cells in Translation: the Governance of Clinical Promise in Regenerative Medicine. Workshop announcement (11-12 May)

["virginie tournay" (vtournay AT yahoo.fr via athena Mailing List) <athena AT services.cnrs.fr>]

Bonjour,

Ci-dessous une annonce susceptible d'intéresser certains d'entre vous.

Bien cordialement,

Virginie Tournay

-----------------------------------------------------------------------------------------
Virginie Tournay
Chargée de recherche CNRS/ Permanent CNRS Researcher
CEVIPOF. Centre de recherches politiques de Sciences Po
98, rue de l'Université. 75 007 Paris
tél. +33 (0)1 45 49 77 27
https://virginietournay.wordpress.com/
http://www.cevipof.com/en/l-equipe/les-chercheurs/chercheurs/bdd/equipe/186

Notes. 

The timing of the schedule may be subject to slight changes. 

For registering to attend the workshop (limited places), please contact Marcelle Bourbier: marcelle.bourbier AT sciencespo.fr

Workshop announcement/ Call for proposals: 'Stem cells in translation: the governance of clinical promise in regenerative medicine' | News and Media

Workshop announcement/ Call for proposals: 'Stem cells in translation: ... Department of Politics and International Relations, University of Oxford

Paris, May 11-12, 2016 CEVIPOF – 98, rue de l’Université – 75007   EUcelLEX workshop   Stem Cells in Translation: the Governance of Clinical Promise in Regenerative Medicine   Organized by EUcelLEX WP6: Alessandro Blasimme (Inserm U1027 Toulouse III, France & University of Zurich, Switzerland), Virginie Tournay (CNRS, Cevipof – SciencesPo, France), Adeline Néron (EHESS - IFRIS, France)
11 May
09:00 – 9:30	Registration
09:30 – 10:00	Welcome messages from FNSP, CEVIPOF-Sciences Po (Madani Cheurfa)
10:00 – 10:15	Introductory notes from the organizers Virginie Tournay, Alessandro Blasimme, Adeline Néron
10:15 – 11:15	Keynote lecture: tba Chairperson: A. Blasimme
11:15 – 11:30	Coffee Break
11:30 – 12:30	First Session RE-IMAGINED COMMUNITIES Chairperson: A. Blasimme ·      Adeline NÉRON (EHESS - IFRIS, France)  Community making and un-making: values, priorities and (in)compatibilities in regenerative medicine. ·      Mathieu JACOMY (Médialab - SciencesPo, France) and Virginie TOURNAY (CNRS, Cevipof – SciencesPo, France) Digital networks, big data and controversial biotechnologies: emerging social representations of stem cells.   Discussion
12:30 – 14:00	Lunch

14:00 – 15:00

Second Session

CLAIMING THE CELL: THE COPRODUCTION OF BIOLOGICAL AND REGULATORY ONTOLOGIES

Chairperson: V. Tournay

·      Aurélie MAHALATCHIMY and Alex FAULKNER (University of Sussex, UK)

The regulatory significance of the Regenerative Medicine concept.

·      Lucie LAPLANE (IHPST – CNRS, France)

Stem cells as anti-cancer targets: the multiple ontologies of innovative therapy.

Discussion

15:00 – 15:15

Coffee Break

15:15 – 16:45

Third session

SOCIOTECHNICAL IMAGINARIES OF REGENERATION (1/2)

Chairperson: A. Néron 

·      Milla HURME (University of Vienna, Austria)

Whose goods, whose science? A case study of narratives in placental stem cell research.

·      Michael MORRISON (HeLEX, University of Oxford, UK).

Stem cell scientists’ perspectives on sharing materials and data in a large international consortium.

·      Noémie MERLEAU-PONTY (EHESS, France) and Michel PUCÉAT (Inserm US910, France)

Cartographie interdisciplinaire d’une lignée cellulaire.

Discussion

19:30 – 22:00

Dinner Party

12 May

09:15 – 10:45

Fourth Session

SOCIOTECHNICAL IMAGINARIES OF REGENERATION (2/2)

Chairperson: A. Blasimme

·      John GARDNER and Andrew WEBSTER (University of York, UK)

The regenerative medicine translational landscape in the UK: Tensions in the pursuit of national ‘health and wealth.’

·      Luca MARELLI (IEO, University of Milan, Italy)

‘Having a Structuring Effect on Europe’. The Innovative Medicines Initiative and the Construction of European induced Pluripotent Stem Cell Research.  

·      Sarah COY (HeLEX, University of Oxford, UK)

Evaluating the ethical, legal and social issues raised through the combination of precision genome engineering with iPSC reprograming technology.

Discussion

10:45 – 11:00

Coffee break

11:00 – 12:00 

Fifth Session

UNDERSTANDING THE STAKES OF CLINICAL TRANSLATION

Chairperson: A. Néron 

·      Alessandro BLASIMME (Inserm U1027 Toulouse III, France & University of Zurich, Switzerland)

Making sense of clinical translation: a discursive topography.

·      Erik AARDEN (University of Vienna, Austria)

Re-imagining Translational Benefits: some lessons from population laboratories.

Discussion

12:00 – 12:30

Art & Science

FRONTIERS OF RE-IMAGINATION

Chairperson: V. Tournay 

·      Annick BUREAUD (France)

Bioart: Creating (with) Life.

 

Discussion

12:30 – 14:00	Lunch
14:00 – 15:00	Ending Keynote Chairperson: V. Tournay ·      Céline GRANJOU (Irstea, France) Anticipating the futures of life and nature?
15:00 – 15:40	General discussion and conclusion
15:40 – 16:00	Concluding remarks